ILiAD Biotechnologies

WESTON, FL · Founded 2026 · Biotech · Private

Live attenuated Bordetella pertussis vaccine (BPZE1)

Claim this profile

Follows are private to you and power your alerts

Updated · iliadbio.com

Sector
Biotech
Headquarters
WESTON, FL
Founded
2026
Latest Form D
$116M, Feb 2026
Total capital
$116M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$116M
1 Form D · last Feb 2026
8 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
7 pending · first 2024
Rank in peer group#397 of 1449

Capital timeline

2026FEDERAL ↑EQUITY ↓Cumulative $116M1st Form D$116M
2026FEDERAL ↑EQUITY ↓Cumulative $116M1st Form D$116M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$116M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1449 peers

Line = median

Biotech · Molecule

  • Granted patents#397 · top 27%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • KEITH RUBINResearcherExecutive OfficerLinked by 2 patents
  • Ariel Pablos-MendezDirectorNamed in SEC Form D filings
  • Avi NaiderDirectorNamed in SEC Form D filings
  • BIN YANDirectorNamed in SEC Form D filings
  • COREY HOROWITZDirectorNamed in SEC Form D filings
  • CUONG DODirectorNamed in SEC Form D filings
Show all 12 people
  • David JohnstonExecutive OfficerNamed in SEC Form D filings
  • Eric EdidinDirectorNamed in SEC Form D filings
  • KEN SOLOVAYExecutive OfficerNamed in SEC Form D filings
  • Mario BarroDirectorNamed in SEC Form D filings
  • Ventures, LLC Seedlings Life ScienceDirectorNamed in SEC Form D filings
  • William SteinkraussExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 9
Show all 9 patent records
  • Treatment and prevention of neuropathology associated with neurodegenerative diseasesJun 24, 2025 · US 12,337,018Granted
  • Treatment and prevention of neuropathology associated with neurodegenerative diseasesMay 21, 2024 · US 11,986,499Granted
  • Lyophilized Live Bordetella VaccinesJun 8, 2023 · Application 18159550Pending
  • Treatment and prevention of neuropathology associated with neurodegenerative diseasesApplication 63114909Pending
  • Manufacture of a stable lyophilized formulation of the live attenuated pertussis vaccine BPZE1Application 63066020Pending
  • Nasal Irrigation Assembly And SystemApplication PCTUS2015015385Pending
  • Irrigation AssemblyApplication PCTUS2013067445Pending
  • Treatment And Prevention Of Neuropathology Associated With Neurodegenerative DiseasesApplication PCTUS2021059579Pending
  • Lyophilized Live Bordetella VaccinesApplication PCTUS2021046055Pending

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .